BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38176309)

  • 1. Role of tumor budding and fibrotic cancer stroma in head and neck squamous cell carcinoma.
    Mitha M; Aden D; Zaheer S; Alvi Y; Chintamani
    Pathol Res Pract; 2024 Jan; 253():155052. PubMed ID: 38176309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histomorphological Evaluation of Desmoplastic Tumor Stroma in Malignant Ovarian Surface Epithelial Tumors.
    Ahuja S; Zaheer S; Ranga S
    J Midlife Health; 2023; 14(2):107-111. PubMed ID: 38029034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma.
    Xie N; Wang C; Liu X; Li R; Hou J; Chen X; Huang H
    J Oral Pathol Med; 2015 Apr; 44(4):266-72. PubMed ID: 25169851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour budding in head and neck squamous cell carcinoma - a systematic review.
    Almangush A; Salo T; Hagström J; Leivo I
    Histopathology; 2014 Nov; 65(5):587-94. PubMed ID: 24897954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostication for oral squamous cell carcinoma patients based on the tumour-stroma ratio and tumour budding.
    Dourado MR; Miwa KYM; Hamada GB; Paranaíba LMR; Sawazaki-Calone Í; Domingueti CB; Ervolino de Oliveira C; Furlan ECB; Longo BC; Almangush A; Salo T; Coletta RD
    Histopathology; 2020 May; 76(6):906-918. PubMed ID: 31984527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancytokeratin immunostained tumor buds and cytoplasmic pseudofragments are reliable early predictive variables for regional lymph node metastatic risk assessment of oral squamous cell carcinoma.
    Sowmya SV; Rao RS; Prasad K
    Indian J Dent Res; 2020; 31(6):904-910. PubMed ID: 33753662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.
    Shaban M; Raza SEA; Hassan M; Jamshed A; Mushtaq S; Loya A; Batis N; Brooks J; Nankivell P; Sharma N; Robinson M; Mehanna H; Khurram SA; Rajpoot N
    J Pathol; 2022 Feb; 256(2):174-185. PubMed ID: 34698394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the combination of tumor-stroma ratio, tumor-infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early-stage oral squamous cell carcinoma prognosis.
    Silva GVD; da Silva Dolens E; Paranaíba LMR; Ayroza ALC; Gurgel Rocha CA; Almangush A; Salo T; Brennan PA; Coletta RD
    J Oral Pathol Med; 2023 May; 52(5):402-409. PubMed ID: 36149755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study in the expression of p53, EGFR, TGF-alpha, and cyclin D1 in verrucous carcinoma, verrucous hyperplasia, and squamous cell carcinoma of head and neck region.
    Wu M; Putti TC; Bhuiya TA
    Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):351-6. PubMed ID: 12607604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin α11 is overexpressed by tumour stroma of head and neck squamous cell carcinoma and correlates positively with alpha smooth muscle actin expression.
    Parajuli H; Teh MT; Abrahamsen S; Christoffersen I; Neppelberg E; Lybak S; Osman T; Johannessen AC; Gullberg D; Skarstein K; Costea DE
    J Oral Pathol Med; 2017 Apr; 46(4):267-275. PubMed ID: 27699902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adverse prognostic effect of tumor budding on the evolution of cutaneous head and neck squamous cell carcinoma.
    Gonzalez-Guerrero M; Martínez-Camblor P; Vivanco B; Fernández-Vega I; Munguía-Calzada P; Gonzalez-Gutierrez MP; Rodrigo JP; Galache C; Santos-Juanes J
    J Am Acad Dermatol; 2017 Jun; 76(6):1139-1145. PubMed ID: 28314684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic evaluation of tumour budding in oral squamous cell carcinoma: Evidenced by CD44 expression as a cancer stem cell marker.
    Niranjan KC; Raj M; Hallikeri K
    Pathol Res Pract; 2023 Nov; 251():154883. PubMed ID: 37898041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-stroma ratio can predict lymph-node metastasis in cT1/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade.
    Sakai T; Saito Y; Tateishi Y; Yamazawa S; Fukuoka O; Kobayashi K; Omura G; Akashi K; Yoshida M; Ando M; Ebihara Y; Yamasoba T
    Int J Clin Oncol; 2022 Dec; 27(12):1818-1827. PubMed ID: 36197545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-stroma ratio is a valuable prognostic factor for oral tongue squamous cell carcinoma.
    Kang J; Su M; Xu Q; Wang C; Yuan X; Han Z
    Oral Dis; 2023 Mar; 29(2):628-638. PubMed ID: 34455659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial spin labeling perfusion-weighted MR imaging: correlation of tumor blood flow with pathological degree of tumor differentiation, clinical stage and nodal metastasis of head and neck squamous cell carcinoma.
    Abdel Razek AAK; Nada N
    Eur Arch Otorhinolaryngol; 2018 May; 275(5):1301-1307. PubMed ID: 29582174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune cell infiltration, tumour budding, and the p53 expression pattern are important predictors in penile squamous cell carcinoma: a retrospective study of 152 cases.
    Hrudka J; Prouzová Z; Kendall Bártů M; Hojný J; Čapka D; Zavillová N; Matěj R; Waldauf P
    Pathology; 2023 Aug; 55(5):637-649. PubMed ID: 37316384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer.
    Stögbauer F; Beck S; Ourailidis I; Hess J; Poremba C; Lauterbach M; Wollenberg B; Buchberger AMS; Jesinghaus M; Schirmacher P; Stenzinger A; Weichert W; Boxberg M; Budczies J
    Br J Cancer; 2023 Jun; 128(12):2295-2306. PubMed ID: 37045906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Correlation of Tumour Budding and Tumour-Stroma Ratio with Clinicopathological Factors in Oral Squamous Cell Carcinoma.
    Verma L; Singh K; Pujani M; Jain M; Chandoke RK; Agarwal C; Chauhan V; Raychaudhuri S; Jain A
    Sultan Qaboos Univ Med J; 2024 Feb; 24(1):52-57. PubMed ID: 38434449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of basement membrane laminin in histological grades of oral squamous cell carcinoma: A semiquantitative analysis.
    Shruthy R; Sharada P; Swaminathan U; Nagamalini B
    J Oral Maxillofac Pathol; 2013 May; 17(2):185-9. PubMed ID: 24250076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.